A detailed history of Beacon Pointe Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 25,594 shares of AZN stock, worth $1.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
25,594
Previous 27,681 7.54%
Holding current value
$1.7 Million
Previous $2.16 Million 7.6%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$76.67 - $87.62 $160,010 - $182,862
-2,087 Reduced 7.54%
25,594 $1.99 Million
Q2 2024

Aug 12, 2024

BUY
$66.81 - $80.83 $743,996 - $900,122
11,136 Added 67.31%
27,681 $2.16 Million
Q1 2024

May 14, 2024

BUY
$61.03 - $69.57 $170,273 - $194,100
2,790 Added 20.28%
16,545 $1.12 Million
Q4 2023

Feb 08, 2024

SELL
$61.89 - $69.28 $166,298 - $186,155
-2,687 Reduced 16.34%
13,755 $926,000
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $254,925 - $281,852
3,931 Added 31.42%
16,442 $1.11 Million
Q2 2023

Aug 11, 2023

SELL
$69.91 - $75.81 $135,905 - $147,374
-1,944 Reduced 13.45%
12,511 $895,000
Q1 2023

May 12, 2023

BUY
$63.15 - $71.6 $124,468 - $141,123
1,971 Added 15.79%
14,455 $1 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $31,821 - $41,348
587 Added 4.93%
12,484 $846,000
Q3 2022

Nov 09, 2022

SELL
$53.02 - $135.75 $13,520 - $34,616
-255 Reduced 2.1%
11,897 $650,000
Q2 2022

Aug 11, 2022

SELL
$59.26 - $71.14 $595,977 - $715,454
-10,057 Reduced 45.28%
12,152 $804,000
Q1 2022

May 17, 2022

BUY
$55.72 - $67.12 $667,358 - $803,896
11,977 Added 117.05%
22,209 $1.47 Million
Q4 2021

Feb 14, 2022

BUY
$54.02 - $63.83 $280,363 - $331,277
5,190 Added 102.94%
10,232 $596,000
Q3 2021

Nov 15, 2021

SELL
$55.56 - $60.79 $5,333 - $5,835
-96 Reduced 1.87%
5,042 $303,000
Q2 2021

Aug 17, 2021

BUY
$48.42 - $60.18 $248,781 - $309,204
5,138 New
5,138 $308,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.